SMTL ID : 3g8i.1

Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x RO7: (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid(Non-covalent)

RO7.1: 22 residues within 4Å: Chain A: L.49, V.57, F.75, C.77, C.78, Q.79, S.82, Y.116, F.120, L.123, M.132, L.133, V.134, I.141, L.146, I.156, M.157, K.160, H.242, V.246, L.262, Y.266 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.49, A:V.57, A:F.120, A:L.123, A:V.134, A:V.134, A:I.141, A:L.146 Hydrogen bonds: A:S.82, A:S.82 Salt bridges: A:H.242

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Benardeau, A. et al., Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-06-02

Peptides

Peroxisome proliferator-activated receptor alpha: A
Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
Z

Peroxisome proliferator-activated receptor alpha

Nuclear receptor coactivator 1

Related Entries With Identical Sequence